[ad_1]
We have a very, almost 100% immune response in fact, then the Russian is a very good vaccine and we are waiting for phase 3, said among others the professor of the Faculty of Medicine of the University of Patras and member of the Expert Committee from the Ministry of Health, Mr. Charalambos Gogos. on the course of the new coronavirus pandemic.
“Now we have data on the Russian vaccine. The Lancet is an excellent magazine of the first of the world, so we have a very, almost 100% immune response in fact, then it is a very good vaccine and we are waiting for phase 3 where approved. The platform it uses is similar to the one used by other companies. “
At the same time, he pointed out that we are in a critical situation with respect to the period in which this appears because the autumn season is approaching and there we must give all our strength ”.
“We need to protect the health system free from the virus. We need constant information directed to the world. Control is very important.” Vaccines are needed for the winter, “he noted.
“It is clear that the pandemic continues with a great worldwide spread.” No one can question its size or its impact, “Gogos said.
The professor of Infectious Diseases spoke about “the outbreak of the coronavirus in Europe”, a kind of “second wave in Europe in which Greece also participates”, as he characteristically said and added: “In Europe, the phenomenon is related to the rise of restrictive measures “.
The professor also addressed the “emerging issue” as he described it, with cases in closed structures. “We are in a critical situation, I would say in terms of the period in which the cases appear. It is time to do everything you can to reduce the problem. “That is where we must put all our means,” he stressed.
The professor expressed his optimism for the autumn, that observing the measures for coronavirus, “we will reduce other diseases” such as seasonal flu.
Mr. Gogos called on citizens not to have “open ears to misinformation.” “Another scientific discussion and another misinformation.” I am optimistic that we have better treatment options, “he said.
At the same time, for treatment, he stated, “we are 9 months away from the initial appearance of the cases and the disease, where at that time we did not have many data and studies. Since then we have many studies showing specific therapeutic approaches. We know a lot about the pathogenesis of the virus. When does this hyper-inflammatory syndrome deviate and make it catastrophic for the health and poor outcomes of patients? So we have data on various antiviral drugs, mainly for one of those that entered the treatment algorithm around the world, but also in Greece, and a lot of data on the role of corticosteroids in the outcome of the disease when given on time. . With these data, the panel of experts created a therapeutic algorithm based on scientific data and it has been delivered to all centers to be applied to patients with coronary heart disease, while it has two parts: the treatment of outpatients and the second for the most serious cases to be treated. at the hospital.
Regarding the results of this treatment, there are data in the literature that improve the result by up to 30% in some cases. We are processing the Greek data now, but so far it shows that the outcome of our patients in Greece is quite good and compared to the world map, the mortality in Greece is below the average mortality in European countries that are also advanced , so we have good data for our country as well. “
